Drug Trial Radar · NCT03216486
An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta
Last checked: Nov 19, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Withdrawn
Enrollment
0
Actual
Start
Oct 31, 2017
Primary completion
Nov 1, 2018
Study completion Nov 1, 2018
Sponsor
- Lead sponsor
- Ultragenyx Pharmaceutical IncIndustry
- Sponsor type
- Industry
- Collaborators
- Mereo BioPharma
- First posted
- Jul 13, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to investigate the effect of BPS804 on strength/quality of bone in patients with Type I, III or IV Osteogenesis imperfecta using a special type of CT scanner. Participants will be treated for 1 year.
Conditions
- Osteogenesis Imperfecta
Interventions
BPS804Drug
IV administration of BPS804 in 5% Dextrose solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in radial Trabecular Volumetric Bone Mineral Density (mgHA/cm3)Time frame: 12 months
- Change in radial bone strength on Finite Element Analysis (N)Time frame: 12 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Mereo Investigator Site
Albuquerque, New Mexico
Mereo Investigator Site
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.